Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ho-Shin Gwak

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Metabolites|December 23, 2021
Experimental Assessment of Leptomeningeal Metastasis Diagnosis in Medulloblastoma Using Cerebrospinal Fluid Metabolomic ProfilesJi Hye Im, Byong Chul Yoo, Jun Hwa Lee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 6, 2020
Postoperative radiotherapy for WHO grade II-III intracranial ependymoma in adults: An intergroup collaborative study (KROG 18-06/KNOG 18-01)Chan Woo Wee, Il Han Kim, Chul-Kee Park, et al.
Plos Biology|May 21, 2015
Pigment Epithelium-Derived Factor (PEDF) Expression Induced by EGFRvIII Promotes Self-renewal and Tumor Progression of Glioma Stem CellsJinlong Yin, Gunwoo Park, Tae Hoon Kim, et al.
Nature Communications|June 14, 2020
ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophagesJinlong Yin, Sung Soo Kim, Eunji Choi, et al.
Plos Biology|January 12, 2016
Correction: Pigment Epithelium-Derived Factor (PEDF) Expression Induced by EGFRvIII Promotes Self-renewal and Tumor Progression of Glioma Stem CellsJinlong Yin, Gunwoo Park, Tae Hoon Kim, et al.
Journal of Neuro-Oncology|March 25, 2018
Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup studyTaeryool Koo, Do Hoon Lim, Ho Jun Seol, et al.
Cancer Research|July 30, 2017
Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ SignalingJinlong Yin, Young Taek Oh, Jeong-Yub Kim, et al.
Journal of Neuro-Oncology|August 12, 2018
Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup studyTaeryool Koo, Do Hoon Lim, Ho Jun Seol, et al.
Journal of Korean Neurosurgical Society|February 15, 2014
Temozolomide salvage chemotherapy for recurrent anaplastic oligodendroglioma and oligo-astrocytomaHo-Shin Gwak, Gi Taek Yee, Chul-Kee Park, et al.
Brain Tumor Research and Treatment|May 12, 2020
A National Consensus Survey for Current Practice in Brain Tumor Management I: Antiepileptic Drug and Steroid UsageSung Kwon Kim, Jangsup Moon, Jin Mo Cho, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Metabolites|December 23, 2021
Experimental Assessment of Leptomeningeal Metastasis Diagnosis in Medulloblastoma Using Cerebrospinal Fluid Metabolomic ProfilesJi Hye Im, Byong Chul Yoo, Jun Hwa Lee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 6, 2020
Postoperative radiotherapy for WHO grade II-III intracranial ependymoma in adults: An intergroup collaborative study (KROG 18-06/KNOG 18-01)Chan Woo Wee, Il Han Kim, Chul-Kee Park, et al.
Plos Biology|May 21, 2015
Pigment Epithelium-Derived Factor (PEDF) Expression Induced by EGFRvIII Promotes Self-renewal and Tumor Progression of Glioma Stem CellsJinlong Yin, Gunwoo Park, Tae Hoon Kim, et al.
Nature Communications|June 14, 2020
ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophagesJinlong Yin, Sung Soo Kim, Eunji Choi, et al.
Plos Biology|January 12, 2016
Correction: Pigment Epithelium-Derived Factor (PEDF) Expression Induced by EGFRvIII Promotes Self-renewal and Tumor Progression of Glioma Stem CellsJinlong Yin, Gunwoo Park, Tae Hoon Kim, et al.
Journal of Neuro-Oncology|March 25, 2018
Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup studyTaeryool Koo, Do Hoon Lim, Ho Jun Seol, et al.
Cancer Research|July 30, 2017
Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ SignalingJinlong Yin, Young Taek Oh, Jeong-Yub Kim, et al.
Journal of Neuro-Oncology|August 12, 2018
Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup studyTaeryool Koo, Do Hoon Lim, Ho Jun Seol, et al.
Journal of Korean Neurosurgical Society|February 15, 2014
Temozolomide salvage chemotherapy for recurrent anaplastic oligodendroglioma and oligo-astrocytomaHo-Shin Gwak, Gi Taek Yee, Chul-Kee Park, et al.
Brain Tumor Research and Treatment|May 12, 2020
A National Consensus Survey for Current Practice in Brain Tumor Management I: Antiepileptic Drug and Steroid UsageSung Kwon Kim, Jangsup Moon, Jin Mo Cho, et al.
Pageof 11